Chan ATC - Search Results

1

Investigational drugs for nasopharyngeal carcinoma.

Ma BBY, Hui EP, Chan ATC. Ma BBY, et al. Among authors: chan atc. Expert Opin Investig Drugs. 2017 Jun;26(6):677-685. doi: 10.1080/13543784.2017.1324568. Epub 2017 May 8. Expert Opin Investig Drugs. 2017. PMID: 28446055 Review.

2

Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, Gatter KC, Johnson PJ, Harris AL. Hui EP, et al. Clin Cancer Res. 2002 Aug;8(8):2595-604. Clin Cancer Res. 2002. PMID: 12171890

3

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.

Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, Mo F, Lai M, Ho S, Huang DP, Johnson PJ. Chan AT, et al. J Natl Cancer Inst. 2002 Nov 6;94(21):1614-9. doi: 10.1093/jnci/94.21.1614. J Natl Cancer Inst. 2002. PMID: 12419787

4

Nasopharyngeal cancer.

Chan AT, Teo PM, Johnson PJ. Chan AT, et al. Cancer Treat Res. 2003;114:275-93. doi: 10.1007/0-306-48060-3_11. Cancer Treat Res. 2003. PMID: 12619546 Review. No abstract available.

5

Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients.

Chan KC, Zhang J, Chan AT, Lei KI, Leung SF, Chan LY, Chow KC, Lo YM. Chan KC, et al. Cancer Res. 2003 May 1;63(9):2028-32. Cancer Res. 2003. PMID: 12727814

6

Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.

Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ, Lo YM. Leung SF, et al. Cancer. 2003 Jul 15;98(2):288-91. doi: 10.1002/cncr.11496. Cancer. 2003. PMID: 12872347 Free article.

7

Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.

Ma BB, Poon TC, To KF, Zee B, Mo FK, Chan CM, Ho S, Teo PM, Johnson PJ, Chan AT. Ma BB, et al. Head Neck. 2003 Oct;25(10):864-72. doi: 10.1002/hed.10307. Head Neck. 2003. PMID: 12966511

8

A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma.

Hui EP, Poon TC, Teo PM, Mo F, Zee B, Leung SF, Ho S, Mok TS, Kwan WH, Johnson PJ, Chan AT. Hui EP, et al. Radiother Oncol. 2003 Oct;69(1):53-62. doi: 10.1016/s0167-8140(03)00248-2. Radiother Oncol. 2003. PMID: 14597357

9

Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group.

Hui EP, Leung SF, Au JS, Zee B, Tung S, Chua D, Sze WM, Law CK, Leung TW, Chan AT. Hui EP, et al. Cancer. 2004 Jul 15;101(2):300-6. doi: 10.1002/cncr.20358. Cancer. 2004. PMID: 15241827 Free article.

10

Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.

Chan AT, Ma BB, Lo YM, Leung SF, Kwan WH, Hui EP, Mok TS, Kam M, Chan LS, Chiu SK, Yu KH, Cheung KY, Lai K, Lai M, Mo F, Yeo W, King A, Johnson PJ, Teo PM, Zee B. Chan AT, et al. J Clin Oncol. 2004 Aug 1;22(15):3053-60. doi: 10.1200/JCO.2004.05.178. J Clin Oncol. 2004. PMID: 15284255 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page